Interstitial cystitis clinical studies are currently studying new treatment methods and exploring aspects of the condition. For example, a drug commonly used to treat depression may work to block nerve signals from the bladder -- reducing pain and frequent urination associated with the condition. Patients who join interstitial cystitis clinical studies have the first chance to benefit from treatments that have shown promise in earlier research.
Interstitial Cystitis Clinical Studies: An Overview
Doctors are hard at work conducting many types of
interstitial cystitis clinical studies. These research studies are designed to answer important questions about the disorder and to find out whether new approaches are safe and effective. Interstitial cystitis clinical studies already have led to many advances, and researchers continue to search for more effective methods for dealing with the condition.
Current Areas of Focus in Interstitial Cystitis Clinical Studies
Interstitial cystitis research scientists are currently testing new approaches to treatment. One clinical study is looking at the effectiveness of
amitriptyline (
Elavil®) for
interstitial cystitis treatment. Amitriptyline has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of
depression, but researchers believe the drug may work to block nerve signals that trigger pain in the bladder and may also decrease muscle spasms in the bladder, helping to cut both pain and frequent urination.
Other interstitial cystitis clinical studies are looking at various aspects of the condition, such as how the components of urine may injure the bladder and what role organisms identified by nonstandard methods may play as one of the
causes of interstitial cystitis.
Potential Benefits of Participation in Interstitial Cystitis Clinical Studies
Patients who join interstitial cystitis clinical studies have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disorder. Although interstitial cystitis clinical studies may pose some risks, researchers take careful steps to protect their patients.